MultiWave technology is based on combining two types of waves: an ultrasound wave that provides exceptional imaging in B-mode, and a shear wave, ShearWave™ Elastography, which measures and displays the stiffness of tissue in kilopascals. ShearWave Elastography is user-skill independent with reproducible results.
Aixplorer is CE mark approved since 2008 and has FDA clearance since 2009 and has several clinical applications: breast (and 3D breast), thyroid, abdomen, liver, musculo-skeletal, prostate, and gynaecological, obstetrics.
SuperSonic Imagine has both a direct sales and distribution network in more than 50 countries worldwide, including Konica Minolta in Japan. SuperSonic Imagine holds the exclusive right, title and interest to 30 international patents and submissions in diagnostic imaging and therapy applications. Company investors include Edmond de Rothschild Investment Partners (EdRIP), Auriga Partners, Crédit Agricole Private Equity (CAPE), NBGI Ventures, Bioam, Mérieux Développement, Wellington Partners, Innobio, Canon (NYSE:CAJ), and IXO Private Equity.
Market capitalization (22-Sep-2017)
Closing share price (22-Sep-2017)